Critical Appraisal of Amyloid Lowering Agents in AD

PURPOSE OF REVIEW: According to the amyloid cascade hypothesis, removing amyloid beta (Aβ) should cure Alzheimer’s disease (AD). In the past three decades, many agents have been tested to try to lower Aβ production, prevent Aβ aggregation, and dissolve Aβ deposits. However, the paucity in definitive...

Descripción completa

Detalles Bibliográficos
Autores principales: Decourt, Boris, Boumelhem, Fadel, Pope, Evans D., Shi, Jiong, Mari, Zoltan, Sabbagh, Marwan Noel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Dementia (K.S. Marder, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192384/
https://www.ncbi.nlm.nih.gov/pubmed/34110536
http://dx.doi.org/10.1007/s11910-021-01125-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192384/
https://www.ncbi.nlm.nih.gov/pubmed/34110536
http://dx.doi.org/10.1007/s11910-021-01125-y

Ejemplares similares